Posaconazole Liquid vs Tablet Formulation in Lung Transplant Recipients

ConclusionsWe suggest the use of POS‐Tab is appropriate for prophylaxis and therapy of Aspergillus infections in LTx‐recipients, since POS‐Tab displayed more reliable PTLs with no added adverse events. However, we recommend regular drug monitoring for POS‐Liq and for therapy with POS‐Tab and that immunosuppressant levels are monitored closely when the posaconazole formulation is switched.This article is protected by copyright. All rights reserved.

Source: Mycoses - November 6, 2017 Category: Research Authors: D telzer, A Weber, F Ihle, S Matthes, F Ceelen, G Zimmermann, N Kneidinger, R Schramm, H Winter, M Zoller, M Vogeser, J Behr, C Neurohr Tags: Original Article Source Type: research